{"nct_id":"NCT05629585","title":"A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2022-11-28","start_date_type":"ACTUAL","primary_completion_date":"2027-09-20","primary_completion_date_type":"ESTIMATED","completion_date":"2030-01-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}